We previously published a study showing that fentanyl toxicology testing rates were low and fentanyl positivity rates were high for ED overdose encounters.1 Since that publication, California, Maryland, and Pennsylvania have enacted laws to require fentanyl testing in patients who have a urine drug screen performed in an acute hospital encounter.2,3,4 Additionally, our data tracker has demonstrated an increase in fentanyl testing over time for patients aged 18 and older.5 While we are encouraged by these improvements, we sought to further understand whether these changes have been similar across age groups and for patients who live in rural or urban areas.
We found that fentanyl testing rates in ED overdose encounters have risen across all age groups, tripling for most between Q1 2021 and Q4 2023, as seen in Figure 1. Patients aged 13 to 17 experienced the greatest increase in testing rates during this period, going from 5% of overdose encounters having a fentanyl screening to 26%. Patients aged 35 to 64 had the highest fentanyl positivity rate in all quarters, closely followed by those aged 18 to 34.
We also evaluated fentanyl toxicology testing and positivity by the patient’s rural-urban classification (RUCA). We found that fentanyl testing in urban areas occurred twice as often compared to rural areas in most quarters studied, with patients living in rural areas being tested for fentanyl in 9% of overdose encounters in Q4 2023 and patients living in urban areas being tested 20% of the time. However, the positivity rate for patients living in urban and rural areas has remained similar over the years.
Even with the increase in testing rates over recent years, positivity rates have remained fairly steady, indicating that the additional testing now is catching positive cases that could have been missed in the past.